pharmaceutical company
S.2543, Prescription Drug Pricing Reduction Act
S.1895, Lower Health Care Costs Act
H.R. 3, Lower Drug Costs Now Act
H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act
H.R.1865, FY2020 Further Consolidated Appropriations Act
Administration review of drug pricing policies S.2543, Prescription Drug Pricing Reduction Act
S.1895, Lower Health Care Costs Act
H.R. 3, Lower Drug Costs Now Act
H.R.2375/ S.64, Preserve Access to Affordable Generics and Biosimilars Act
H.R.1865, FY2020 Further Consolidated Appropriations Act
Administration review of drug pricing policies
HCR - Health Issues PHA - Pharmacy
64 - Federal Trade Commission (FTC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 64 - Federal Trade Commission (FTC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
POLSINELLI PC
1401 Eye Street, NW, Suite 800, Washington, DC, 20005, US
SYLVIA STANOJEV KORNEGAY JAMES DAVIDSON STEVEN STRANNE HARRY ANASTASIOS SPORIDIS JULIUS W HOBSON SYLVIA STANOJEV KORNEGAY JAMES DAVIDSON STEVEN STRANNE HARRY ANASTASIOS SPORIDIS JULIUS W HOBSON